CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Clinical trials for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial targets painful lupus skin rash
Disease control Recruiting nowThis study is testing whether an experimental drug called VENT-03 can reduce the severity of skin rashes caused by lupus. About 24 adults with active lupus skin rashes will take either VENT-03 or a placebo for 4 weeks, then all will take VENT-03 for 8 more weeks. Researchers will…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Massive online survey aims to unlock lupus mysteries
Knowledge-focused Recruiting nowThis is an online registry, not a treatment study. It aims to better understand the lives of people with lupus by collecting information about their diagnosis, symptoms, treatments, and quality of life. Up to 10,000 adults and children with lupus (or their caregivers) can partici…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Sponsor: Lupus Foundation of America • Aim: Knowledge-focused
Last updated Apr 04, 2026 08:22 UTC